Form 4 holding
President and CEO, Director
Viracta Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 100,000
- Estimated value
- $49,320
- Report date
- 01 Dec 2023
- Price
- $0.4932
- Ownership
- Direct
Mark Rothera - President and CEO, Director at Viracta Therapeutics, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- VIRX
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mark Rothera since 29 Aug 2025
Reported holdings for Mark Rothera in Viracta Therapeutics, Inc.
Form 4 holding
President and CEO, Director
Viracta Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 475,000
- Estimated value
- Report date
- 12 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mark Rothera in Viracta Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.